Home Theravia

Theravia

acquired
-
Developer of treatments for rare and debilitating diseases

Basic Information

Theravia is an international pharmaceutical company dedicated to providing treatments for patients with rare and debilitating diseases. The company develops therapies related to inherited metabolic disorders, hematology, oncology, immunology, and gene and cell therapy, thereby offering pharmaceutical products to meet patients' medical needs when they are unmet.
Theravia
France
15~50 people
January 01, 2002
--